Tag: CA Clover Intermediate II Investments

India-based Piramal Pharma secures $490m investment from Carlyle Group

pharmanewsdaily- June 30, 2020

The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate's pharma ... Read More